A detailed history of Convergence Investment Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 2,345 shares of BSX stock, worth $241,699. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,345
Holding current value
$241,699
% of portfolio
0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$83.62 - $91.5 $196,088 - $214,567
2,345 New
2,345 $209,000
Q2 2018

Aug 07, 2018

SELL
$26.84 - $34.32 $53,357 - $68,228
-1,988 Closed
0 $0
Q1 2018

May 14, 2018

BUY
$25.2 - $28.54 $50,097 - $56,737
1,988 New
1,988 $54,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $148B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Convergence Investment Partners, LLC Portfolio

Follow Convergence Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.